In vivo persistence and immuno-pathogenesis of Mycobacterium abscessus in a new Xenopus tadpole model
脓肿分枝杆菌在新爪蟾蝌蚪模型中的体内持久性和免疫发病机制
基本信息
- 批准号:10350750
- 负责人:
- 金额:$ 23.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-04-11 至 2024-03-31
- 项目状态:已结题
- 来源:
- 关键词:AcidsAddressAllelesAmphibiaAnimal ModelAntibiotic ResistanceAntibiotic TherapyB-LymphocytesBacteriaBiological AssayBreathingBronchiectasisBurkholderia cepaciaChronicChronic lung diseaseComparative BiologyCystic FibrosisDevelopmentDiseaseEmbryoExhibitsFertilizationFlow CytometryGene MutationGenesGenetic DeterminismGenomeGenus MycobacteriumHistologyHomologous GeneHumanImmuneImmune responseImmune systemImmunityImmunocompetentImmunocompromised HostInfectionInterferonsInvestigationKnock-outKnockout MiceLabelLaboratory OrganismLeukocytesLiverLower respiratory tract structureLungLung diseasesLung infectionsMammalsMicrobial BiofilmsMicroscopyModelingMorphologyMulti-Drug ResistanceMusMycobacterium abscessusMycobacterium marinumMyeloid CellsPathogenesisPathogenicityPathologyPatient IsolatorsPhenotypePlayPositioning AttributePrevalenceProductionProliferatingPseudomonas aeruginosaRefractoryResearch ProposalsResistanceRoleSkinSoilSystemT-LymphocyteTadpolesTissuesTransgenic OrganismsVirulence FactorsVisualizationWaterXenopusXenopus laevisZebrafishadaptive immunityarmcell envelopechronic infectionemerging pathogenhost colonizationhuman diseasehuman tissueimmunopathologyin vivoinsightintravital microscopylung pathogenmacrophagemutantnon-tuberculosis mycobacterianovelpathogenpreventpromoterrespiratory pathogenresponsetranscriptomics
项目摘要
Owing to its increasing prevalence, persistence, multidrug resistance, pathogenicity and treatment
challenges, the non-tuberculosis mycobacterium (NTM) Mycobacterium abscessus (Mab) has become a
serious threat to humans with chronic lung diseases such as bronchiectasis and cystic fibrosis, as well as
immunocompromised patients. However, Mab is still understudied compared to other pathogenic
mycobacteria. In addition, there is a limitation in current animal models that poses a real challenge for
investigating the respective roles of two Mab morphotypes, smooth (S) and rough (R), in lung
immunopathology, persistence and host immune response. The clearance of Mab in immunocompetent and
even immunocompromised mice prevent the study of chronic infection, and while for zebrafish embryos are
instrumental for investigating Mab infection, they cannot be used to model a pulmonary infection and T cell
involvement. Thus, there is a need for complementary animal models. Since like zebrafish embryos, X. laevis
tadpoles are transparent, allowing visualization of pathogen dissemination, but that in addition they do have
functional lungs and exhibit an immune system including T cells remarkably similar to humans, we propose to
develop a X. laevis tadpole model of Mab infection that mimics human pulmonary disease. Relying on an
established comparative biology approach to study immunity to mycobacteria in tadpoles and our recent
demonstration that both S and R Mab morphotypes readily infect tadpoles, disseminate in tadpole lungs and
persist up to 50 days, the objective of the exploratory research proposal is to investigate in vivo for over 40
days Mab persistence, and immuno-pathogenesis. Specifically, to address the hypothesis that persistent R
Mab is more actively proliferating and immunopathogenic than S Mab in X. laevis tadpoles we propose:
, by comparing
the host immune response and persistence of R and S Mab in the lung and other tissues using intravital
(1) Characterize immune-pathogenesis in tadpole lungs during persisting Mab infection
microscopy flow cytometry and transcriptomics as well as fluorescently labeled Mab and transgenic tadpoles
with fluorescent macrophages.
(2) Investigate the relevance of S to R morphotype switch in vivo for pathogenesis and persistence
, by
using a promoter system to control the S to R switch following infection and examining effect of switches on
persistence, pathogenicity and host immune response.
(3) Investigate genetic determinants of Mab immune-pathogenesis
, using selected Mab deletion
mutants generated by allelic exchange of Mab-specific genes as well as gene homologs shared by Gram-
negative lung pathogens.
We anticipate that novel insights relevant to human will be gathered. Our collaborative team is uniquely
positioned to carry these studies due to our background and complementary expertise.
由于其流行率、持久性、多药耐药性、致病性和治疗日益增加,
挑战,非结核分枝杆菌(NTM)结核分枝杆菌(Mab)已成为
严重威胁人类的慢性肺部疾病,如支气管扩张和囊性纤维化,以及
免疫功能低下的患者。然而,单克隆抗体与其他致病性
分枝杆菌此外,目前的动物模型存在局限性,这对免疫学研究构成了真实的挑战。
研究两种Mab形态型,光滑(S)和粗糙(R),在肺中的各自作用,
免疫病理学、持久性和宿主免疫应答。单抗在免疫活性和
甚至免疫功能低下的小鼠也阻止了慢性感染的研究,而斑马鱼胚胎则是
虽然它们是研究Mab感染的工具,但它们不能用于模拟肺部感染和T细胞
参与。因此,需要补充的动物模型。因为像斑马鱼胚胎一样,X.爪蟾
蝌蚪是透明的,可以看到病原体的传播,但除此之外,它们还有
功能正常的肺,并表现出免疫系统,包括与人类非常相似的T细胞,我们建议
发展出一个X。Mab感染的光滑蝌蚪模型,其模拟人类肺部疾病。援用
建立了比较生物学方法来研究蝌蚪对分枝杆菌的免疫力,
证明S和R Mab形态型都容易感染蝌蚪,在蝌蚪肺中传播,
持续长达50天,探索性研究提案的目的是在体内研究超过40
天单抗持久性,和免疫发病机制。具体地说,为了解决这个假设,
单克隆抗体在X.我们建议:
通过比较
使用活体内注射的方法,观察R和S Mab在肺和其他组织中的宿主免疫应答和持久性。
(1)Mab持续感染期间蝌蚪肺中免疫发病机制的特征
显微镜流式细胞术和转录组学以及荧光标记单抗和转基因蝌蚪
荧光巨噬细胞。
(2)研究体内S至R形态型转换与发病机制和持续性的相关性
得子茶杯.
使用启动子系统来控制感染后的S到R转换,并检查转换对
持久性、致病性和宿主免疫反应。
(3)研究单克隆抗体免疫发病机制的遗传决定因素
,使用选定的Mab缺失
通过单克隆抗体特异性基因的等位基因交换产生的突变体以及革兰氏阴性菌共有的基因同源物,
阴性肺部病原体。
我们期待与人类相关的新见解将被收集。我们的合作团队是独一无二的
由于我们的背景和互补的专业知识,我们有能力进行这些研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Martin S. Pavelka其他文献
Martin S. Pavelka的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Martin S. Pavelka', 18)}}的其他基金
In vivo persistence and immuno-pathogenesis of Mycobacterium abscessus in a new Xenopus tadpole model
脓肿分枝杆菌在新爪蟾蝌蚪模型中的体内持久性和免疫发病机制
- 批准号:
10608077 - 财政年份:2022
- 资助金额:
$ 23.1万 - 项目类别:
Analysis of a novel peptidoglycan assembly pathway in mycobacteria
分枝杆菌中新型肽聚糖组装途径的分析
- 批准号:
10203747 - 财政年份:2018
- 资助金额:
$ 23.1万 - 项目类别:
Analysis of a novel peptidoglycan assembly pathway in mycobacteria
分枝杆菌中新型肽聚糖组装途径的分析
- 批准号:
10431963 - 财政年份:2018
- 资助金额:
$ 23.1万 - 项目类别:
New tools for studying M. abscessus pathogenesis
研究脓肿分枝杆菌发病机制的新工具
- 批准号:
8814644 - 财政年份:2015
- 资助金额:
$ 23.1万 - 项目类别:
New tools for studying M. abscessus pathogenesis
研究脓肿分枝杆菌发病机制的新工具
- 批准号:
9107388 - 财政年份:2015
- 资助金额:
$ 23.1万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 23.1万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 23.1万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 23.1万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 23.1万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 23.1万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 23.1万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 23.1万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 23.1万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 23.1万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 23.1万 - 项目类别:
Research Grant